HNRNPA2B1 and neoplasm: Furthermore, HNRNPA2B1 exhibited higher expression in the tumor group of T cells, while HNRNPC showed increased expression in the tumor group of B cells, serving as a key mediator of PD-L1 expression in ESCC [52].